San Diego, CA, June 7, 2016 – Biomatrica, Inc., a producer of reagents and devices for sample collection and analysis in diagnostics systems, nucleic acid testing, and biobanking, announced today that it has received certification from British Standards Institution Group America, Inc. that the company complies with the requirements of ISO 13485:2003 for an integrated quality management system across all functions of the business, from design and development to manufacturing and supply.
“This is an important advancement in our strategy of embedding our products in the platforms of leading diagnostics and life science products companies,” said Nick Ecos, Biomatrica’s President and CEO. “Our chemically-treated sample collection tubes are being increasingly adopted by diagnostics companies, to test for cancer in blood, for example. We are also increasingly providing precision chemistry to engineer manual laboratory workflows onto the microfluidics systems of diagnostics manufacturers. ISO 13485 certification provides an important level of assurance to our clients that we will be compliant with their regulatory standards.”